我国药害事件保险救济制度研究  

Study on China's Insurance Remedy of Drug-Induced Injury Event

作　　者：徐徕[1,2] 杜文民 游开铭 王广平 余伯阳[1] 

机构地区：[1]中国药科大学,江苏南京210009 [2]上海市食品药品安全研究中心,上海200233

出　　处：《上海金融》2010年第11期32-36,共5页Shanghai Finance

摘　　要：本文通过对国外药害事件救济制度和国内类似责任险险种的立法和实践经验的借鉴,对目前国内几种药害救济制度的构建方案对比分析,在探索归责原则基础之上提出了基于商业保险模式的药害事件救济制度的设计和安排。鉴于我国基本国情和现行法律规制基础,药害事件的商业保险救济制度是当前较为可行的方案之一,是构建全面药害救济机制的一种可行模式。The paper refers to the remedy system of drug-induced injury event in foreign countries and domestic legislation and practices in relevant fields, compares several designs of remedy system, and proposes its own remedy design of drug-induced injury event based on commercial insurance model under imputation principle. In view of China＇s basic national condition and the rule of law and regulation, the author deems that the commercial insurance remedy is a feasible plan, and is a transitional model for us to build the compensation mechanism of drug-induced injury event.

关 键 词：药害事件 保险 救济制度 设计 

分 类 号：F842.4[经济管理—保险]